KEXING BIOPHARM CO., LTD. financial statements, including revenue, expenses, profit, and loss
The total revenue of 688136 for the last quarter is 286.58 M CNY, and it's 9.62% lower compared to the previous quarter. The net income of Q4 23 is -135.98 M CNY.